Oct 2026· Preparative Biochemistry & Biotechnology· pp.
1-10
· 0 citations· 25 references
Medicine
Abstract
Plasmid DNA (pDNA) is a critical starting material for the production of viral vectors, mRNA therapeutics, and recombinant proteins. The rapid growth of these modalities has increased demand for high-quality pDNA. Despite previous investigations of chaotropic additives and anion exchange chromatography for nucleic acid purification, significant plasmid losses remain a challenge in membrane-based processes. In this study, we developed and optimized a Mustang™ Q XT anion exchange membrane chromatography process to improve pDNA recovery directly from clarified lysate using a Design of Experiments (DOE) approach. Process parameters, including pH, conductivity, loading conditions, and buffer additives, were evaluated to identify factors affecting plasmid recovery and RNA removal. Arginine and urea were identified as significant process enhancers, increasing plasmid recovery from approximately 50% to as high as 93% while improving resolution between pDNA and RNA species. The additives also reduced the conductivity required for plasmid elution, improving recovery and chromatographic selectivity. Additional studies demonstrated that guanidine and histidine provided similar benefits. These improvements were achieved without additional chromatography or polishing steps, enabling direct processing of clarified lysate in a rapid, low-shear workflow. The findings provide a practical, scalable strategy for enhancing pDNA recovery using strong anion exchange membrane chromatography.
Plasmid DNA (pDNA) is a key raw material for advanced therapeutic modalities, including gene therapy, mRNA production, and DNA vaccination, requiring efficient and scalable downstream processing strategies. Increasing demand places stringent requirements on purification processes in terms of yield, impurity removal, pr...
Matilde Costa, S. Cardoso, I. Marçal et al.· Membranes· 0 citations
The rapid advancing of cell and gene therapy has increased the demand for plasmid DNA used in viral vector manufacturing. The production of transfection-grade plasmid DNA remains a critical bottleneck, particularly for academic and emerging manufacturing facilities, due to the high cost and limited scalability of exist...
E. Bulatov, G. Nigmatulla, V. Keyer et al.· Eurasian journal of applied...· 0 citations
High-quality, properly linearized plasmid DNA (pDNA) is a decisive upstream determinant of in vitro transcription (IVT) performance, impacting mRNA yield, integrity, and batch-to-batch consistency. We developed immobilized restriction enzyme reactors (IMERs) on monolithic supports and benchmarked EcoRI, NdeI, and HindI...
Maša Nabergoj, Špela Peršič Debenjak, Polona Skrt et al.· Biotechnology and Bioenginee...· 0 citations
The selection of a simple, robust and efficient extraction method for periplasmic or soluble recombinant proteins from
Escherichia coli
is critical for maximizing recovery, preserving protein quality and reducing downstream processing costs.
Present study proposes an optimized osmotic shock method...
Richa Katiyar, A. Rathore· Journal of Chemical Technolo...· 0 citations
Protein A chromatography is a key unit operation in biopharmaceutical purification, widely used to capture monoclonal antibodies (mAbs) from harvest cell culture fluid (HCCF). In addition to its primary function, protein A chromatography is also frequently tested for its ability to remove viruses. Although protein A sp...
Lukas Döring, S. Schubert, Nora Roos et al.· Biotechnology progress (Prin...· 0 citations
This study demonstrates that transfection-derived quality attributes affect purification outcomes and overall vector quality, and highlights the necessity of strategically balancing multiple quality attributes during transfection optimization.
E. Ramadhani, Yasuo Tsunaka, Mitsuko Fukuhara et al.· Journal of Bioscience and Bi...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.